Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Mettens

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
British Medical Bulletin|August 15, 2002
Life-style vaccinesPascal Mettens, Philippe Monteyne
BMC Immunology|October 24, 2015
Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigensMarie-Cécile Mortier, Erik Jongert, Pascal Mettens, et al.
Vaccine|September 18, 2007
Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategiesJennifer L Oliver, Ghazaleh Pashmi, Paul Barnett, et al.
Infection and Immunity|November 15, 2006
Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02AClara Brando, Lisa A Ware, Helen Freyberger, et al.
Vaccine|May 31, 2012
Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trialIsabel Leroux-Roels, Sheron Forgus, Fien De Boever, et al.
Vaccine|February 9, 2008
Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigenPascal Mettens, Patrice M Dubois, Marie-Ange Demoitié, et al.
FEMS Immunology and Medical Microbiology|March 14, 2009
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatisRhea N Coler, Ajay Bhatia, Jean-Francois Maisonneuve, et al.
Plos One|April 10, 2015
Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaquesClarisse Lorin, Yannick Vanloubbeeck, Sébastien Baudart, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 18, 2012
Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaquesClarisse Lorin, Lawrence Segal, Johann Mols, et al.
AIDS (London, England)|June 10, 2014
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trialEleonora G Thacher, Matthias Cavassini, Régine Audran, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
British Medical Bulletin|August 15, 2002
Life-style vaccinesPascal Mettens, Philippe Monteyne
BMC Immunology|October 24, 2015
Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigensMarie-Cécile Mortier, Erik Jongert, Pascal Mettens, et al.
Vaccine|September 18, 2007
Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategiesJennifer L Oliver, Ghazaleh Pashmi, Paul Barnett, et al.
Infection and Immunity|November 15, 2006
Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02AClara Brando, Lisa A Ware, Helen Freyberger, et al.
Vaccine|May 31, 2012
Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trialIsabel Leroux-Roels, Sheron Forgus, Fien De Boever, et al.
Vaccine|February 9, 2008
Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigenPascal Mettens, Patrice M Dubois, Marie-Ange Demoitié, et al.
FEMS Immunology and Medical Microbiology|March 14, 2009
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatisRhea N Coler, Ajay Bhatia, Jean-Francois Maisonneuve, et al.
Plos One|April 10, 2015
Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaquesClarisse Lorin, Yannick Vanloubbeeck, Sébastien Baudart, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 18, 2012
Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaquesClarisse Lorin, Lawrence Segal, Johann Mols, et al.
AIDS (London, England)|June 10, 2014
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trialEleonora G Thacher, Matthias Cavassini, Régine Audran, et al.
Pageof 2